196 related articles for article (PubMed ID: 8241347)
1. High PAI activity with correlation to triglyceride and HDL cholesterol values in patients with coronary artery disease with no difference in survivors of myocardial infarction.
Ihnken K; Speiser W; Ruf W; Thiel W; Schlepper M; Müller-Berghaus G
Ann Hematol; 1993 Nov; 67(5):237-44. PubMed ID: 8241347
[TBL] [Abstract][Full Text] [Related]
2. [Decreased fibrinolytic capacity in coronary patients by increased plasminogen activator inhibitor activity].
Ihnken K; Speiser W; Müller-Berghaus G; Beyersdorf F; Schlepper M; Satter P
Helv Chir Acta; 1992 Jan; 58(4):503-8. PubMed ID: 1582860
[TBL] [Abstract][Full Text] [Related]
3. Fibrinolytic parameters and insulin resistance in young survivors of myocardial infarction with heterozygous familial hypercholesterolemia.
Sebestjen M; Zegura B; Guzic-Salobir B; Keber I
Wien Klin Wochenschr; 2001 Feb; 113(3-4):113-8. PubMed ID: 11253736
[TBL] [Abstract][Full Text] [Related]
4. Plasminogen activator inhibitor activity in diabetic and nondiabetic survivors of myocardial infarction.
Gray RP; Patterson DL; Yudkin JS
Arterioscler Thromb; 1993 Mar; 13(3):415-20. PubMed ID: 8443145
[TBL] [Abstract][Full Text] [Related]
5. Plasma and platelet plasminogen activator inhibitor-1 in patients with acute myocardial infarction.
Soeki T; Tamura Y; Fukuda N; Ito S
Jpn Circ J; 2000 Aug; 64(8):547-53. PubMed ID: 10952148
[TBL] [Abstract][Full Text] [Related]
6. [Fibrinolytic system in patients with myocardial infarction and other coronary disease risk factors].
Moreno JA; Gálvez MM; Cornudella R; Angós JA; Romero MS; Gutiérrez M
Sangre (Barc); 1994 Apr; 39(2):111-6. PubMed ID: 8059288
[TBL] [Abstract][Full Text] [Related]
7. Plasma levels of tissue plasminogen activator and plasminogen activator inhibitor-1 are correlated with the presence of transplant coronary artery disease in cardiac transplant recipients.
Warshofsky MK; Wasserman HS; Wang W; Teng P; Sciacca R; Apfelbaum M; Schwartz A; Michler RE; Mancini DM; Cannon PJ; Rabbani LE
Am J Cardiol; 1997 Jul; 80(2):145-9. PubMed ID: 9230149
[TBL] [Abstract][Full Text] [Related]
8. Regulation of tissue-type plasminogen activator-mediated fibrinolysis by plasminogen activator inhibitor type-1 in patients with ischaemic heart disease: possible unfavourable effect of diuretics.
Pedersen OD; Gram J; Bagger H; Keller N; Jespersen J
Coron Artery Dis; 1994 Jul; 5(7):617-23. PubMed ID: 7952424
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator inhibitor 1 is elevated in the children of men with premature myocardial infarction.
Rallidis LS; Megalou AA; Papageorgakis NH; Trikas AG; Chatzidimitriou GI; Tsitouris GK
Thromb Haemost; 1996 Sep; 76(3):417-21. PubMed ID: 8883280
[TBL] [Abstract][Full Text] [Related]
10. Fibrinolytic variables in postmenopausal women with unstable coronary artery disease.
Nielsen NE; Logander E; Swahn E
J Thromb Thrombolysis; 2001 Dec; 12(3):217-23. PubMed ID: 11981104
[TBL] [Abstract][Full Text] [Related]
11. Plasma concentrations of fibrinolytic factors in the subacute phase of myocardial infarction predict recurrent myocardial infarction or sudden cardiac death.
Soeki T; Tamura Y; Shinohara H; Sakabe K; Onose Y; Fukuda N
Int J Cardiol; 2002 Oct; 85(2-3):277-83. PubMed ID: 12208595
[TBL] [Abstract][Full Text] [Related]
12. Circadian fluctuations of plasminogen activator inhibitor and tissue plasminogen activator levels in plasma of patients with unstable coronary artery disease and acute myocardial infarction.
Huber K; Rosc D; Resch I; Schuster E; Glogar DH; Kaindl F; Binder BR
Thromb Haemost; 1988 Dec; 60(3):372-6. PubMed ID: 3149044
[TBL] [Abstract][Full Text] [Related]
13. Plasma Lp(a) and t-PA-PAI-1 complex levels in coronary heart disease.
Süer S; Ulutin T; Sönmez H; Kökoğlu E; Uçişik N; Bayram C; Sultuybek G
Thromb Res; 1996 Jul; 83(1):77-85. PubMed ID: 8837306
[TBL] [Abstract][Full Text] [Related]
14. Impairment of plasma fibrinolysis in young survivors of myocardial infarction with silent ischaemia.
Grzywacz A; Elikowski W; Psuja P; Zozulińska M; Zawilska K
Blood Coagul Fibrinolysis; 1998 Apr; 9(3):245-9. PubMed ID: 9663707
[TBL] [Abstract][Full Text] [Related]
15. Alterations in the fibrinolytic system components during acute myocardial infarction.
Ioannidou-Papayannaki E; Lefkos N; Boudonas G; Efthimiadis A; Psirropoulos D; Vogas V; Papadopoulos I; Klonizakis I
Acta Cardiol; 2000 Aug; 55(4):247-53. PubMed ID: 11041123
[TBL] [Abstract][Full Text] [Related]
16. Laboratory evaluation of fibrinolysis in patients with a history of myocardial infarction.
Chandler WL; Stratton JR
Am J Clin Pathol; 1994 Aug; 102(2):248-52. PubMed ID: 8042597
[TBL] [Abstract][Full Text] [Related]
17. Increased plasminogen activator inhibitor-1 activity in offspring of type 2 diabetic patients: lack of association with plasma insulin levels.
Gürlek A; Bayraktar M; Kirazli S
Diabetes Care; 2000 Jan; 23(1):88-92. PubMed ID: 10857975
[TBL] [Abstract][Full Text] [Related]
18. Tissue plasminogen activator and plasminogen activator inhibitor-1 in stroke patients.
Lindgren A; Lindoff C; Norrving B; Astedt B; Johansson BB
Stroke; 1996 Jun; 27(6):1066-71. PubMed ID: 8650716
[TBL] [Abstract][Full Text] [Related]
19. Plasminogen activator and plasminogen activator inhibitor activities in men with coronary artery disease.
Oseroff A; Krishnamurti C; Hassett A; Tang D; Alving B
J Lab Clin Med; 1989 Jan; 113(1):88-93. PubMed ID: 2783330
[TBL] [Abstract][Full Text] [Related]
20. Fibrinolytic activity is similar in physically active men with and without a history of myocardial infarction.
Fernhall B; Szymanski LM; Gorman PA; Milani J; Paup DC; Kessler CM
Arterioscler Thromb Vasc Biol; 1997 Jun; 17(6):1106-13. PubMed ID: 9194761
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
